Triple-negative breast cancers (TNBC) are invasive breast cancers with absent or minimal expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) and account for ~10–15% of all breast cancers1. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.